RBC Capital Keeps Their Hold Rating on Incyte (INCY)
RBC Capital analyst Brian Abrahams maintained a Hold rating on Incyte (INCY – Research Report) on January 21 and set a price target of $70.00.
RBC Capital Remains a Hold on SAGE Therapeutics (SAGE)
RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) on January 21 and set a price target ...
CNN22h
Pre-markets
Before markets open, start your day smart. Get essential news and analysis with CNN Business' daily newsletter.
Indiatimes8h
Forex News
The Indian rupee strengthened on Wednesday, tracking gains in most of its regional peers, while dollar-rupee forward premiums declined on the back of likely dollar-rupee buy/sell swaps conducted by ...